Blog
Choosing the Right Antibody Generation Method: Phage Display, Hybridoma, or Single B Cell Cloning
There have been remarkable advancements in antibody generation technology over the years, offering scientists many techniques to generate antibodies for various applications ranging from discovery research to diagnostics and therapeutics. Three prominent methods for...
Employee Spotlight: Amy (Zichun) Wang, PhD
Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Amy (Zichun) Wang, PhD Amy (Zichun) Wang, PhD Senior Director of Cell Biology, Biology and Pharmacology Department Q&A with Amy What...
Equilibrium Dialysis vs. Ultracentrifugation for In Vitro Protein Binding Assays
In a modern drug discovery setting, in vitro protein binding assays are essential to assess the binding affinity and characteristics of a drug molecule with plasma proteins. Two commonly used methods for in vitro protein binding assays are equilibrium dialysis and...
In Vitro Safety Pharmacology: A Roadmap to Safer and More Effective Drugs
In vitro safety pharmacology profiling plays a crucial role in the drug development process by providing essential information about the potential safety and efficacy of new drug candidates. This approach involves conducting experiments in controlled laboratory...
3 Reasons to Introduce ADME Assays ASAP in Drug Discovery
Modern Drug Discovery Workflows There are several reasons why it is important to introduce in vitro absorption, distribution, metabolism, and excretion (ADME) assays as early as possible into a modern drug discovery workflow, especially for biotech companies. Here are...
In Vivo Intricacies: The Power of Orthotopic and Metastatic Models in Brain Tumor Studies
Brain tumors are a major cause of cancer-related death, and metastatic brain tumors are particularly difficult to treat. Brain tumors pose significant challenges to scientists in terms of understanding their development and progression, and finding effective treatment...
Employee Spotlight: Yan Wang, PhD
Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Yan Wang, PhD Yan Wang, PhD Director, Peptide Chemistry Q&A with Yan What is your favorite part of your role here as a Director of...
Employee Spotlight: Manny Ventura, PhD
Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Manny Ventura, PhD Manny Ventura, PhD Senior Director and Site Head at ChemPartner US Q&A with Manny What is your favorite part of...
Unlocking Success: Key Factors to Consider When Choosing the Right CDMO/CRO Partner
In order to stay competitive in the biopharmaceutical industry, companies are increasingly turning to outsourcing as a means of gaining an advantage. With the many competing Contract Development and Manufacturing Organizations (CDMOs) and Contract Research...
Advantages of Integrated Drug Development Models
The race to first-in-human clinical trials has become more critical than ever for drug developers. The FDA has even developed 4 major tracks to speed up the process and make drugs available to patients as fast as possible: Fast Track: Facilitates drug development and...
Exciting Upcoming Events: 2023
Throughout the year, ChemPartner attends events and conferences around the world not only to stay up to date with the latest trends but to share our expertise with the industry. Mark your calendar with this year's top biopharma conferences and events, and be sure to...
Outsourcing Chiral Separations
It is critical to isolate unique isomers for targeted structural design and accurate assay readouts in small molecule development. Chiral intermediate or final compound single enantiomer isolation is necessary for key assays. Where chiral synthesis is challenging or...
Headquarters
1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203
Contact Us
China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000
English 
Chinese